Rigel Pharma (RIGL) Sees Wild Rollercoaster Pre-Open Trading Amid Data

August 30, 2016 8:43 AM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Rigel Pharma (NASDAQ: RIGL) is seeing wild gyrations in pre-open trade following this morning's data. Shares initially went positive, then negative, then positive, then negative and now positive again.

Analyst have made positive comments. JP Morgan said the stock can climb 90% today on the data and BMO raised its price target to $6, or over 100% upside from current levels.

Shares last traded up 12.5%.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

FDA, Momentum Movers, Trader Talk

Related Entities

JPMorgan, Pre Market Movers

Add Your Comment